Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Fosfluridine tidoxil in Actinic Keratosis
2006-005525-33Phase 2Completed
- Sponsor
- Heidelberg Pharma AG
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing Fosfluridine tidoxil with Placebo (2 arms). Started Dec 2006; status: completed.
02
Drugs
fosfluridine tidoxil
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2006-005525-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005525-33.